Press Releases

Perrigo Announces FDA Final Approval for Desloratadine

12/27/2011

Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Desloratadine tablets (5 mg).